Article
Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity.
Oncogene - 8 Jul 1999
Legoix P, Bluteau O, Bayer J, Perret C, Balabaud C, Belghiti J, Franco D, Thomas G, Laurent-Puig P, Zucman-Rossi J
Abstract excerpt
To determine the frequency of Wnt/Wingless beta catenin pathway alteration in human hepatocellular carcinoma, a beta catenin and APC gene mutation screening was performed in a series of 119 tumors. An activating beta catenin mutation in exon 3 was found in 18% of the cases. Among tumors lacking beta catenin mutation, no APC mutation has been evidenced in a subset of 30 cases tested. The correlation between beta...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
